Perspectives for Cancer Care and Research in Central and Eastern Europe
Background: Discrepancies between the outcomes of cancer patients between Western European and Central and Eastern European (CEE) countries have often been observed. Despite the enormous economic and civilizational progress made in these countries after the abolishment of the communist regime, structural problems persist.
Summary: The present article reviews the domains of medical oncology education, human resources in oncology, cancer care, and clinical research in Central and Eastern European in order to comprehensively assess the current situation and needs, describe important initiatives, and also propose ways to impr...
Source: Oncology Research and Treatment - December 2, 2022 Category: Cancer & Oncology Source Type: research
Radiation Therapy Induced Systemic Abscopal Effects Through Immune System Activation in Patients with Metastatic Renal Cell Carcinoma
Conclusions: Collectively, these findings suggest that radiation therapy can induce sy stemic abscopal effects through immune system activation and thus the addition of immunotherapeutic agents increases the potential to boost the systemic abscopal responses in patients with advanced cancers including RCC. (Source: Oncology Research and Treatment)
Source: Oncology Research and Treatment - November 8, 2022 Category: Cancer & Oncology Source Type: research
Prelims
Oncol Res Treat 2022;45:1 –4 (Source: Oncology Research and Treatment)
Source: Oncology Research and Treatment - November 7, 2022 Category: Cancer & Oncology Source Type: research
35. Deutscher Krebskongress, Krebsmedizin: Schnittstellen zwischen Innovation und Versorgung, 13. –16. November 2022, Berlin
Oncol Res Treat 2022;45:5 –284 (Source: Oncology Research and Treatment)
Source: Oncology Research and Treatment - November 7, 2022 Category: Cancer & Oncology Source Type: research
35. Deutscher Krebskongress, Krebsmedizin: Schnittstellen zwischen Innovation und Versorgung, 23. - 26. Februar 2022, Berlin
Oncol Res Treat 2022;45:5 –284 (Source: Oncology Research and Treatment)
Source: Oncology Research and Treatment - November 7, 2022 Category: Cancer & Oncology Source Type: research
Society Bulletins
Oncol Res Treat 2022;45:709 –716 (Source: Oncology Research and Treatment)
Source: Oncology Research and Treatment - October 31, 2022 Category: Cancer & Oncology Source Type: research
PharmaNews
Oncol Res Treat 2022;45:706 –708 (Source: Oncology Research and Treatment)
Source: Oncology Research and Treatment - October 31, 2022 Category: Cancer & Oncology Source Type: research
Platinum-Based Chemotherapy in Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma: Summary of Evidence and Application in Clinical Practice
Background: Different therapeutic options are available for the treatment of advanced or metastatic pancreatic ductal adenocarcinoma (PDAC). Platinum-based multi-agent chemotherapy regimens, such as FOLFIRINOX, are important elements in the multidisciplinary management of PDAC.Summary: At least one third of patients with metastatic PDAC are eligible for treatment with FOLFIRINOX. Eligibility criteria include good performance status and the absence of relevant comorbidities. However, chemotherapies can potentially be associated with serious adverse events, such as diarrhea or polyneuropathies. Here, we review relevant data ...
Source: Oncology Research and Treatment - October 28, 2022 Category: Cancer & Oncology Source Type: research
Platinum-based chemotherapy in locally advanced or metastatic pancreatic ductal adenocarcinoma (PDAC): summary of evidence and application in clinical practice
Background: Different therapeutic options are available for the treatment of advanced or metastatic pancreatic ductal adenocarcinoma (PDAC). Platinum-based, multiagent chemotherapy regimens, such as FOLFIRINOX, are important elements in multidisciplinary management of PDAC. Summary: At least one third of patients with metastatic PDAC are eligible for treatment with FOLFIRINOX. Eligibility criteria include good performance status and the absence of relevant comorbidities. However, chemotherapies can potentially be associated with serious adverse events, such as diarrhea or polyneuropathies. Here, we review relevant data fro...
Source: Oncology Research and Treatment - October 28, 2022 Category: Cancer & Oncology Source Type: research
Male Breast Cancer: Therapy-Induced Toxicities, Psychological Distress, and Individual Patient Goals during Oncological Inpatient Rehabilitation
Conclusions: Psychological distress and somatic side effects are common in MBC. These data demonstrate the importance of routine screening for psychological distress and the high need for psycho-oncological therapy (regardless of gender) in multimodal oncological rehabilitation. (Source: Oncology Research and Treatment)
Source: Oncology Research and Treatment - October 20, 2022 Category: Cancer & Oncology Source Type: research
Male breast cancer (MBC) – Therapy-induced toxicities, psychological distress and individual patient goals during oncological inpatient rehabilitation
Conclusions. Psychologic al distress and somatic side effects are common in MBC. These data demonstrate the importance of routine screening for psychological distress and the high need for psycho-oncological therapy (regardless of gender) in multimodal oncological rehabilitation. (Source: Oncology Research and Treatment)
Source: Oncology Research and Treatment - October 20, 2022 Category: Cancer & Oncology Source Type: research
Recent Advances in Castleman Disease
Background: Castleman disease (CD) encompasses a spectrum of rare disorders with characteristic histopathological features. Unicentric Castleman disease (UCD) is a benign, local hyperplasia of lymphoid tissue that is usually curable. Multicentric Castleman disease (MCD) manifests as a potentially life-threatening systemic disease with complex symptomatology which is mostly due to an overproduction of interleukin-6 (IL-6) or dysregulation of IL-6-related signaling pathways. From a therapeutic perspective, it is important to distinguish idiopathic MCD (iMCD) from those cases that are associated with the human herpes virus 8 ...
Source: Oncology Research and Treatment - October 11, 2022 Category: Cancer & Oncology Source Type: research
Society Bulletins
Oncol Res Treat 2022;45:627 –638 (Source: Oncology Research and Treatment)
Source: Oncology Research and Treatment - September 29, 2022 Category: Cancer & Oncology Source Type: research
PharmaNews
Oncol Res Treat 2022;45:624 –626 (Source: Oncology Research and Treatment)
Source: Oncology Research and Treatment - September 29, 2022 Category: Cancer & Oncology Source Type: research
